Mr Pritesh Jain

Keros Therapeutics, Lexington (United States of America)

Follow

Contributor content

RKER-012, a novel modified ActRIIB ligand trap, attenuated right ventricular cardiomyopathy in a preclinical model of pulmonary arterial hypertension.

Presentation

RKER-012, a novel modified ActRIIB ligand trap, attenuated right ventricular cardiomyopathy in a preclinical model of pulmonary arterial hypertension.

ESC 365 is supported by

novartis

Explore sponsored resources